Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | APAF1 | O14727 | 2/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | S100A4 | P26447 | 3/20 | 0.49 |
| ▸ | CDC25A | P30304 | 2/20 | 0.49 |
| ▸ | CDC25B | P30305 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.49 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572112 | 0.95 | ALDH1A1 (0.56) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL572045 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL571607 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL572005 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL571286 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL572109 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL571040 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL571017 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL15695046 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E | |
| SCHEMBL17296068 | 0.93 | ALDH1A1 (0.58) | PKMALDH1A1MAPTTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3615502-B1 | THERAPEUTIC COMPOUNDS AND METHODS | UNIV TASMANIA (AU) | 2023-06-21 | — | — | EP | disclosed |
| US-10934253-B2 | Therapeutic compounds and methods | UNIVERSITY OF TASMANIA (AU) | 2021-03-02 | — | — | US | disclosed |
| US-20200131119-A1 | THERAPEUTIC COMPOUNDS AND METHODS | UNIVERSITY OF TASMANIA (AU) | 2020-04-30 | — | — | US | disclosed |
| WO-2015183985-A2 | THERAPEUTIC COMPOSITIONS INCLUDING NAPHTHOQUINONES AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2015-12-03 | — | — | WO | disclosed |
| EP-2600857-A2 | TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES | Edison Pharmaceuticals, Inc. (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012019029-A2 | TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES | EDISON PHARMACEUTICALS, INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| US-7544438-B2 | Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode | DAIICHI PURE CHEMICALS CO., LTD (JP) | 2009-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131119-A1 | THERAPEUTIC COMPOUNDS AND METHODS | UQCRC1, COX5B, CS | PKM 274/4885ALDH1A1 523/4885MAPT 1209/4885 |
| US-10934253-B2 | Therapeutic compounds and methods | UQCRC1, COX5B, CS | PKM 274/4885ALDH1A1 523/4885MAPT 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.